Donate Now
  • What We're Working On
Partnering With Transgender and Gender Diverse Communities In Research
ENGAGE_PLS
Scientific Study Title:
Ethical partnerships with transGender And Gender diverse communities for conducting pharmacoEpidemiologic research (EnGAGE)
Start Date:
  • June 2022
End Date:
  • January 2023
Research Category
Tags
Mary De Vera, Research Team Member, Arthritis Research Canada
Mary De Vera
MSc, PhD, Associate Director of Training, Senior Scientist, Pharmacoepidemiology

Why do this research?

Reason For Research

Transgender and gender diverse people are more likely to have poorer mental and physical health outcomes. They face more barriers to getting the care they need due to a lack of health research about this unique group, especially as they age. This study gathers information by partnering with the transgender community to understand their priorities and will provide the information to those who serve this group.

What will be done?

Execution of Research

This study partners with the transgender community and other healthcare providers to understand their health needs by:

  1. Individual interviews and focus groups are being held to develop guidelines to address their priorities regarding research studies.
  2. A symposium will be hosted to present the planning activities and to share information gathered for future research and advocacy.
  3. The design of practical tools for researchers to use to design transgender health research that meets the needs of the transgender community.

How are equity, diversity and inclusion addressed?

The nature of this project works on EDI in pharmacoepidemiologic research. Equity, here, acknowledges the lack of ethical research in support of trans and gender-diverse folks and addresses the concern of inclusion through the development of guidelines.

How Can People Get Involved?

Involvement

Transgender and gender-diverse Canadian patients, researchers, community, and institutional stakeholders.

Media and Infographics

Related Research

What We're Working On Right Now

Exploring a New Immune Cell Therapy for People with Autoimmune Diseases

Systemic sclerosis and systemic lupus erythematosus are serious autoimmune diseases that can cause damage to many organs including the skin, lungs and kidneys. In this project, we will study a new type of treatment that may better control these diseases by targeting the immune cells that cause them. If successful, it could reduce inflammation, slow or stop disease progression, and may even help reset the immune system, so that some patients no longer need long-term immune-suppressing medications.
Read More

Understanding how scleroderma affects people over time

People living with scleroderma experience challenges such as pain, disability, and mental health concerns, but we still don’t know much about how these problems change over time or why some people do better than others. For this research project, our goal is to improve our understanding of how scleroderma affects people’s daily lives and identify factors that may predict changes in their health.
Read More

How can we help Canadians age at home to improve health outcomes and support a sustainable healthcare system?

As Canada’s population ages, home care is important for helping older adults remain safely within their homes. Our research team is linking data from the Canadian Longitudinal Study on Aging with health records in British Columbia, Ontario, and New Brunswick, to track patterns of paid and unpaid home care use over time.
Read More